Neurocrine Biosciences to Present at the Deutsche Bank
28th Annual Securities Health Care Conference Tuesday, May 6, 2003
28th Annual Securities Health Care Conference Tuesday, May 6, 2003
SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will present at the 28th Annual Health Care Conference hosted by Deutsche Bank Securities on Tuesday, May 6, 2003 at 11:30 AM Eastern Daylight Time; 8:30 AM Pacific Daylight Time. The presentation will be simultaneously webcast and can be accessed on the Neurocrine website at http://www.neurocrine.com. Viewers are encouraged to visit the Company's website approximately 5 minutes prior to the presentation to download or install any necessary audio software.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. A replay will become available approximately 2 hours after the live webcast. The presentation will be archived until Wednesday, May 21, 2003.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, autoimmunity and certain female and male health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.